New analysis by Airfinity shows there has been a 300% rise in approved new #cancer treatments in the last two decades, with the US Cancer Moonshot Goal achievable by 2048.
Click below to access the full findings on global cancer #disease burden.
https://t.co/y97Zb2UsgQ
Our paper on nucleosome repositioning in CLL is now published in @genomeresearch! Led by @krissyvalp in our lab, collab with @KostareliLab, @KarstenRippe https://t.co/vQcOOUMxnD
▶️Aggressive cancers have shorter nucleosome spacing
▶️Distinguish cancer subtypes from nuc patterns
My first first author paper is out!!!💥 Couldn’t be more excited to share all the work that started as a small project for the @GenSocUK’s Summer Studentship and turned into something a lot bigger! Would never be thankful enough to @TeifLab for giving me this opportunity!!! 🙌🏼
New preprint! Nucleosome repositioning in chronic lymphocytic leukaemia https://t.co/kqNQMxgy4G
▶️Nucleosome changes at few sensitive regions allow patient stratification
▶️Nucleosome repeat length decreases with cancer aggressiveness
▶️Interplay with methylation, TFs and more!
Airfinity is launching a brand new surveillance and analytics solution.
Airfinity Biorisk covers 160 diseases and designed to equip decision makers with a holistic overview of the global infectious disease risk situation.
Learn more here: https://t.co/iN5QxfS7uo
Where will the next #variant of concern come from?
Airfinity has analysed countries where #vaccination rates are low and number of immunocompromised people is high - making mutations more likely.
Read more on the analysis: @TheEconomist
https://t.co/TnMBHEuF0j
NucPosDB: a database of nucleosome positioning in vivo and nucleosomics of cell-free DNA https://t.co/5YVDvGL7ug
For all nucleosome aficionados, with best wishes from Mariya Shtumpf, Kristan Piroeva, Shivam Agrawal, Divya Jacob, Vladimir Teif
Excited to share I’ll be talking about what we’ve been up to at the @TeifLab at the @INC_COST webinar this Thursday - a pretty good reason to finally join Twitter. 🔆